Role of the kringle domain in plasminogen activation with staphylokinase. 1998

K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
Division of Hemostasis and Thrombosis, Institute of Hematology, Jichi Medical School, Tochigi.

We have evaluated the effect of lysine binding sites in kringle structures on the activation of plasminogen with plasmin and staphylokinase (SAK) complex and on the binding of plasminogen to SAK. Activation of native plasminogen (Glu-plasminogen) by a catalytic amount of plasmin-SAK complex increased in the presence of epsilon-amino-n-caproic acid (EACA) and then decreased with higher concentrations of EACA. By contrast, activation of modified plasminogen (Lys-plasminogen) decreased in an EACA-concentration-dependent manner. This decrease was explained by a more than 10-fold higher Km for activation of Lys-plasminogen with a catalytic amount of plasmin-SAK complex in the presence of EACA. EACA was a competitive inhibitor with Ki 0.23 mM. In addition, the Km for activation of mini-plasminogen, which lacks first four kringle structures (K1+2+3+4), was at least 3.5-fold higher than that for the activation of Lys-plasminogen. Furthermore, EACA showed a negligible inhibitory effect on the activation of mini-plasminogen by the plasmin-SAK complex. We observed a similar biphasic effect of EACA on the binding of Glu-plasminogen to SAK and a dose-dependent effect on the Lys-plasminogen binding to SAK by gel filtration methods. Since EACA binds to plasminogen via lysine binding sites in the kringle structure, we propose that the lysine binding site in K1+2+3+4 domain plays a role in the activation of plasminogen by plasmin SAK complex, and in the binding of plasminogen to SAK.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015119 Aminocaproic Acid An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. 6-Aminocaproic Acid,6-Aminohexanoic Acid,epsilon-Aminocaproic Acid,Amicar,CY-116,Capralense,Capramol,Caproamin,Caprocid,Caprolest,Epsamon,Epsikapron,Hemocaprol,Hexalense,6 Aminocaproic Acid,6 Aminohexanoic Acid,CY 116,CY116,epsilon Aminocaproic Acid

Related Publications

K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
February 1960, Nature,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
December 1985, Biochimica et biophysica acta,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
January 1975, Acta biochimica Polonica,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
July 1960, The Biochemical journal,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
October 2005, Biochimica et biophysica acta,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
January 1993, Methods in enzymology,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
May 2003, The Journal of biological chemistry,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
March 2005, FEBS letters,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
October 1994, Thrombosis research,
K Arai, and S Madoiwa, and J Mimuro, and S Asakura, and M Matsuda, and T Sako, and Y Sakata
February 1997, The Journal of biological chemistry,
Copied contents to your clipboard!